[COMBINED RESECTION OF THE CHEST WALL AND DIAPHRAGM IN PATIENTS WITH LUNG CANCER].

Nihon Geka Gakkai zasshi Pub Date : 2016-07-01
Kohei Yokoi
{"title":"[COMBINED RESECTION OF THE CHEST WALL AND DIAPHRAGM IN PATIENTS WITH LUNG CANCER].","authors":"Kohei Yokoi","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Surgical resection remains the only reliable curative method for lung cancer, and combined resection of the primary tumor and involved neighboring structures is performed when possible in patients with locally advanced disease. Lung cancers involving the chest wall and diaphragm are now classified as T3 lesions, and the surgical treatment for those tumors is generally accepted. However, the outcomes are frequently unsatisfactory, and the 5-year survival rates of patients with chest wall and diaphragmatic invasion were reported to be 30-40% and 20-40%, respectively, with mortality rates of 1.8-7.8% for chest wall resection and 0-2.0% for diaphragm resection. In combined resection, a good surgical indication is N0-1 disease, and complete resection is essential. The indication for reconstruction of the chest wall is a large lesion in the caudal area which is not covered by the scapula. If the lesion area in the diaphragmatic muscle is smaller than fist size, it is possible to perform direct suturing with nonabsorbable bladed sutures. In cases of large lesions, diaphragmatic reconstruction using nonabsorbable material is necessary to prevent the herniation of abdominal organs. In the near future, it is hoped that multidisciplinary treatments including surgery will improve the outcomes of patients with those locally advanced lung cancer.</p>","PeriodicalId":19165,"journal":{"name":"Nihon Geka Gakkai zasshi","volume":"117 4","pages":"301-7"},"PeriodicalIF":0.0000,"publicationDate":"2016-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nihon Geka Gakkai zasshi","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Surgical resection remains the only reliable curative method for lung cancer, and combined resection of the primary tumor and involved neighboring structures is performed when possible in patients with locally advanced disease. Lung cancers involving the chest wall and diaphragm are now classified as T3 lesions, and the surgical treatment for those tumors is generally accepted. However, the outcomes are frequently unsatisfactory, and the 5-year survival rates of patients with chest wall and diaphragmatic invasion were reported to be 30-40% and 20-40%, respectively, with mortality rates of 1.8-7.8% for chest wall resection and 0-2.0% for diaphragm resection. In combined resection, a good surgical indication is N0-1 disease, and complete resection is essential. The indication for reconstruction of the chest wall is a large lesion in the caudal area which is not covered by the scapula. If the lesion area in the diaphragmatic muscle is smaller than fist size, it is possible to perform direct suturing with nonabsorbable bladed sutures. In cases of large lesions, diaphragmatic reconstruction using nonabsorbable material is necessary to prevent the herniation of abdominal organs. In the near future, it is hoped that multidisciplinary treatments including surgery will improve the outcomes of patients with those locally advanced lung cancer.

[肺癌患者胸壁膈肌联合切除术]。
手术切除仍然是肺癌唯一可靠的治疗方法,对于局部晚期患者,应尽可能联合切除原发肿瘤和累及的邻近结构。累及胸壁和横膈膜的肺癌现在被归类为T3病变,这些肿瘤的手术治疗被普遍接受。然而,结果往往不令人满意,据报道,胸壁和膈侵犯患者的5年生存率分别为30-40%和20-40%,胸壁切除术死亡率为1.8-7.8%,膈切除术死亡率为0-2.0%。在联合切除中,良好的手术指征是0-1疾病,完全切除是必不可少的。胸壁重建的指征是未被肩胛骨覆盖的尾侧大面积病变。如果横膈肌的病变区域小于拳头大小,则可以使用不可吸收的刀片缝合线进行直接缝合。在大病变的情况下,使用不可吸收的材料进行膈重建是必要的,以防止腹部器官疝出。在不久的将来,包括手术在内的多学科治疗有望改善局部晚期肺癌患者的预后。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信